Skip to Main Content

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN)

Conditions

Diseases of the Nervous System

What is the purpose of this trial?

The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in April 2013, the NBS has been used in over 300 procedures conducted at approximately 20 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 12 months to evaluate procedural success, local control failure rate, and QoL in up to 1,000 patients and up to 50 sites.

  • Trial with
    Monteris Medical Corporation
  • Start Date
    01/22/2017
  • End Date
    06/29/2020
Trial Image

For more information about this study, contact:

Judith Hess

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    02/22/2018
  • Study HIC
    #1507016142REG